Article Type : Case Report
Authors : Adil H, Zahi H, Saouab R, EL Fenni J and EN-Nafaa I
Keywords : Liver sarcoidosis; Liver metastasis; Abdominal pain
Sarcoidosis is a multisystemic,
non-caseous granulomatous disease, of unknown etiology which mainly affects the
lungs and mediastinal lymph nodes. Liver involvement is commonly seen in
multisystemic sarcoidosis, yet; isolated primary hepatic sarcoid localization
is rare, and can be misleading as it may mimic malignant lesions. We describe a
rare case of a-27-years old female, who presented with chronic abdominal pain.
Abdominal imaging showed nodular hepatic lesions suggestive of metastasis,
however; liver biopsy revealed evidence of non-caseating epithelioid cell
granulomas with Langhans multinucleated giant cells suggesting hepatic
sarcoidosis.
We report the case of a
27-year-old female who presented to the gastroenterology department of our
hospital with episodic, long-standing abdominal pain localized to the right
upper quadrant. The patient denied intestinal transit disorders and weight loss.
No particular medical or surgical history was found. Physical examination
showed no anomalies. Routine laboratory test parameters were within normal
limits. Abdominal ultrasound was initially performed. It revealed hepatomegaly
with multiples rounded, well defined hypoechoic nodular lesions. The patient
underwent an abdominal MRI for a better characterization. It revealed an
enlarged liver containing multiple hyperintense nodules with central hypo
signal on T2 weighted and T2-weighted fat-saturated images. They demonstrated a
low signal on T1 weighted images, as compared with the adjacent liver
parenchyma. Diffusion-weighted sequences revealed nodular high signal
intensity. On post contrast T1-weighted fat-saturated images, hepatic nodules
described delayed, heterogenous enhancement and intrahepatic vascular and
biliary structures adjacent to the lesions seemed to be intact. Given the
possibility of metastatic origin, a thoraco-abdominopelvic contrast enhanced CT
was performed, but showed no potentially malignant lesion aside of
hypoattenuating hepatic nodular lesions that enhanced on post contrast images.
Ultrasound-guided liver biopsy was performed. Histological specimen showed
evidence of multinucleated giant cells together with non-caseating epithelioid cell
granulomas in the portal and periportal spaces. Hepatic sarcoidosis was
diagnosed based on such pathological findings. The patient was then treated
with corticosteroid therapy and showed good response (Figures 1-4).
Sarcoidosis is an idiopathic immune-mediated systemic disease, characterized by the presence of non-caseating epithelioid granulomas in the absence of other causes of granulomatous reactions [1,2]. Sarcoidosis prevalence is highest in African Americans and Scandinavian ethnicities. Its main peak of incidence is described for the age group 20–39 years for both genders, with women having a second incidence peak at the ages of 65–69 years [1-3]. Lungs and mediastinal lymph nodes are the mainly targeted sites. Concomitant extrapulmonary is described in 30% of cases. Commonly involved localizations are the abdominal cavity, the skin, the eyes, the central nervous system and the heart. Isolated extra pulmonary involvement remains a rare entity with only 2% of reported sarcoidosis cases [4]. On the other hand, liver involvement was found in 50-80% in patients with multisystemic sarcoidosis; however, isolated hepatic sarcoidosis remains rare; it has been reported only in 13% of cases [5].
Figure 1: Axial T2 weighted (A) and T2 fat-saturated (B) abdominal MRI images demonstrating enlarged liver with multiple hyperintense nodular lesions.
Figure 2: Axial T1 weighted abdominal MRI image demonstrating multiple hypointense hepatic nodular lesions.
Figure 3: Axial diffusion weighted (DWI) abdominal MRI image demonstrating hyperintense hepatic nodular lesions.
Figure 4: Coronal (A) and axial (B) T1 weighted Fat-saturated post contrast abdominal MRI images demonstrating enhancing hepatic nodular lesions.
Hepatic sarcoidosis can
present with a board spectrum of manifestations which varies from asymptomatic
to non-specific signs such as abdominal pain, nausea, vomiting, fever,
arthralgias and right hypochondrium tenderness. Hepatosplenomegaly is described
in 10-40% of cases. Liver cirrhosis and portal hypertension are mostly seen in
long standing cases [6]. Liver function tests are abnormal in 2-60% of cases.
Alkaline phosphatase level is most commonly affected [5]. Other blood tests are
non-specific, however elevated serum angiotensin converting enzyme (s-ACE) may
help narrow differential diagnosis [1]. Imaging modalities play an important
role in assessing the diagnosis and follow up of patients with extrapulmonary
sarcoidosis. Abdominal ultrasonography may demonstrate hepatomegaly with
increased liver echogenicity, which can be either homogenous or diffusely
heterogeneous. Focal nodules, when visible, are round or oval shaped,
hypoechoic, diffusely distributed, ranging in size of 1-2mm to centimeters, with
a tendency of confluence, hypo vascular on Color Doppler and localized in the
portal and periportal spaces. Associated abdominal adenopathies are found in
76% of cases. Enlarged lymph nodes are usually periportal, celiac, paracaval
and para-aortic, with dimensions ranging from 1 cm to 6 cm [6]. Computed
tomography (CT) may reveal hepatomegaly with possible low-density intrahepatic
septa. Liver nodules are hypodense with no mass effect nor peripheral
enhancement. CT scan is also useful in the diagnosis of liver cirrhosis and
portal hypertension subsequent to sarcoidosis [3]. Focal calcifications are
uncommon, and usually presents as round or oval hyperdense, homogeneous foci on
non-enhanced images [7]. MRI typically demonstrates hypointense and hypoenhancing
nodules relative to the adjacent liver parenchyma, with no impact on the
surrounding parenchyma or adjacent vessels. T2-weighted fat-saturated images
are the most conclusive sequences that help differentiate sarcoid nodules from
malignancies, as these appear most frequently hyperintense [3]. However, signal
intensity depicted on T2-weighted images varies according to the degree of
activity of the disease: in case of active inflammation, nodules are
hyperintense with restriction on diffusion weighted imaging (DWI), whereas,
fibrotic nodules show low signal on T2-weighted and diffusion sequences [4]. In
our case, hepatic nodules demonstrated high signal intensity on T2 weighted and
diffusion images with slightly homogenous enhancement on post contrast sequences,
which suggests high inflammation activity. Moreover, absence of mass effect and
intact vascular and biliary structure is highly suggestive of benign or
infiltrative disease [8]. Other signs suggestive of sarcoidosis are irregular
contour of the liver and high periportal signal intensity. MR
cholangiopancreatography is useful in assessing biliary stenosis and dilatation
subsequent to compressive hilar nodules and lymph nodes [3]. CT and MRI are
useful not only for diagnostic purposes but also for follow-up of hepatic
lesions, and to verify the treatment efficiency. They represent a valid
diagnostic aid that can assess the diagnosis of sarcoidosis in many cases,
especially in the presence of characteristic clinical features, however,
definitive diagnosis is based on the biopsy with the demonstration of
non-caseating epithelioid granulomas [1].
The differential
diagnosis of isolated liver nodules includes primitive benign and malignant
tumors, metastasis, tuberculosis, lymphoma, liver abscesses and vascular
lesions. Treatment is based on the symptoms and severity of the disease.
Asymptomatic patients require no treatment; whereas, in symptomatic cases,
corticosteroids and/or ursodeoxcholic acid may be considered. Other
immunosuppressive agents may be required in case of non-response to first line
treatment [1].
Liver sarcoidosis is a
benign entity that can mimic liver metastasis. The radiological presentation
may vary but some subtle signs such as the absence of masse effect on adjacent
structure can help assess the diagnosis. Long stranding sarcoidosis can
progress to end-stage liver disease; hence it should always be considered as a
differential diagnosis so it can be clearly diagnosed and carefully monitored.